- Home
- AIMD vs YCBD Comparison
AIMD vs YCBD Comparison
Compare AIMD & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIMD | YCBD |
|---|---|---|
| Founded | 1984 | 2015 |
| Country | United States | United States |
| Employees | 44 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8M | 7.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AIMD | YCBD |
|---|---|---|
| Price | $1.38 | $0.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 23.5K | ★ 418.0K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.70 |
| Revenue Next Year | N/A | $7.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.44 | $0.17 |
| 52 Week High | $4.50 | $2.56 |
Technical Indicators
Market Signals| Indicator | AIMD | YCBD |
|---|---|---|
| Relative Strength Index (RSI) | 41.25 | 48.91 |
| Support Level | $1.33 | $0.69 |
| Resistance Level | $1.73 | $1.00 |
| Average True Range (ATR) | 0.13 | 0.06 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 16.22 | 71.51 |
Price Performance
Historical ComparisonAbout AIMD Ainos Inc.
Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.